아시아태평양의 단백질체학 시장 : 제공 구분별, 용도별, 국가별 분석, 예측(2025-2035년)

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Proteomics Market

The Asia-Pacific proteomics market is projected to reach $22.15 billion by 2035 from $5.38 billion in 2024, growing at a CAGR of 13.86% during the forecast period 2025-2035. The APAC proteomics industry is growing quickly thanks to notable advancements in high-precision analytical technologies as contemporary mass spectrometry and next-generation sequencing. The desire for deeper protein insights is being driven by the region's increasing emphasis on personalized healthcare, which will facilitate the quicker identification of novel biomarkers and more sophisticated disease-profiling tools. New proteomic applications are being developed more quickly thanks to collaboration between hospitals, biotech firms, and academic institutions, which is bolstered by public-private partnerships and government-backed research efforts. Simultaneously, the need for more advanced diagnostic and early-detection systems is growing due to the increase in chronic diseases and the growing number of elderly people. Proteomics is becoming a crucial pillar in influencing precision medicine and next-generation healthcare innovation throughout the region as APAC continues to invest in life sciences and fortify its clinical research infrastructure.

Market Introduction

Rapid improvements in analytical technologies, growing clinical research capacities, and increased investment in precision medicine are propelling the Asia-Pacific proteomics industry into a high-growth phase. In order to enable high-throughput proteomic workflows, sophisticated mass spectrometry systems, and next-generation protein analysis platforms, nations in the region-especially China, Japan, South Korea, India, and Australia-are expanding their life sciences infrastructure. Government-led research funding, public-private collaborations, and growing cooperation between biotech companies, academic institutions, and hospital networks all contribute to this shift.

Strong diagnostic tools, predictive biomarkers, and early detection solutions are in greater demand as the burden of chronic diseases rises and the number of elderly people increases. Proteomics is becoming a vital enabler, providing practical insights into patient classification, treatment response, and disease processes. The growing use of personalized healthcare is also helping the industry by increasing demand for more in-depth protein-level data to improve treatment strategies.

All things considered, APAC is becoming into a strategic worldwide center for proteomics innovation thanks to its strong manufacturing capabilities, expanding talent pool, and increased emphasis on translational and clinical applications. This establishes the area as a major force behind the development of precision medicine and next-generation healthcare.

Market Segmentation:

Segmentation 1: By Offering

• Sample Preparation
• Proteomics Technologies
  • Reagents and Consumables
  • Instruments
  • Software
• Proteomics Services

Segmentation 2: By Application

• Biomarker Discovery and Validation
• Proteome Profiling and Mapping
• Drug Discovery and Development
• Companion Diagnostics
• Protein-Protein Interactions

Segmentation 3: By Region

• Asia- Pacific

APAC Proteomics Market Trends, Drivers and Challenges

Market Trends

• Strong double-digit growth driven by expanding biomedical research and healthcare modernization across APAC.
• Rapid shift from basic proteomics discovery to translational and clinical applications, especially for biomarker validation and precision medicine.
• Rising adoption of advanced technologies such as high-resolution mass spectrometry, LC-MS/MS, targeted proteomics, and emerging single-cell proteomics.
• Growing dominance of consumables, reagents, and service-based offerings over standalone instrumentation.
• Increasing movement toward automated, end-to-end proteomics workflows to enhance throughput and minimize variability.

Market Drivers

• Expanding pharma and biotech R&D across China, Japan, South Korea, India, and Australia, driving demand for sophisticated proteomic tools.
• Surge in precision medicine initiatives, leading to higher investment in protein biomarker discovery and validation.
• Technological advancements that reduce per-sample analysis time while improving accuracy and sensitivity.
• Rising demand for clinical proteomics applications, including early disease detection, therapy selection, and monitoring.
• Growing role of CROs, centralized facilities, and proteomics-as-a-service providers that reduce the need for high capital expenditure.

Key Market Challenges

• High acquisition and maintenance cost of advanced proteomics instruments, limiting adoption among smaller labs.
• Shortage of trained proteomics and bioinformatics professionals, creating workflow and data analysis bottlenecks.
• Limited standardization across labs and technologies, affecting reproducibility and large-scale clinical deployment.
• Slow and complex regulatory pathways for proteomics-based diagnostics, delaying commercialization.
• Variability in supply chains and availability of localized technical support across different APAC countries

How can this report add value to an organization?

Product/Innovation: This report enables organizations to identify high-value opportunities in the APAC proteomics market. It guides R&D investment strategies, technology adoption, and pipeline optimization, helping companies prioritize initiatives that accelerate biomarker discovery, disease diagnostics, and therapeutic development. By highlighting emerging technologies, strategic collaborations, and platform scalability, this report helps organizations strengthen their competitive positioning and capitalize on the rapid expansion of proteomics across research, clinical, and pharmaceutical applications.

Growth/Marketing: The report delivers in-depth insights into regional adoption trends, emerging markets, and partnership opportunities, supporting strategic market entry and commercialization planning. It enables companies to identify growth potential across offering, technology, application, and end-user segments. By understanding regional R&D investments, regulatory frameworks, and technology adoption rates, organizations can refine marketing, licensing, and collaboration strategies, maximize visibility, and increase return on investment in a competitive global landscape.

Competitive: This report provides comprehensive company profiling, competitive benchmarking, highlighting strategic collaborations, funding activities, mergers, acquisitions, and technology adoption trends. Stakeholders gain a clear understanding of competitor focus areas, R&D priorities, and market positioning. This intelligence allows organizations to identify gaps, anticipate market shifts, and formulate strategies to differentiate themselves, optimize market entry, and maintain leadership in the proteomics ecosystem.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

• 1.1 Market Overview and Ecosystem
• 1.2 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
• 1.3 Supply Chain Analysis
• 1.4 Market Dynamics
  • 1.4.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment, 2024-2035
• 1.5 Trends
  • 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
  • 1.5.2 Growing Proteomics Research to Identify Disease Biomarkers
  • 1.5.3 Significant Number of Collaborations among Market Players
• 1.6 Market Dynamics
  • 1.6.1 Market Drivers
    • 1.6.1.1 Rising Prevalence of Chronic Diseases
    • 1.6.1.2 Continuous Technological Advancements
    • 1.6.1.3 Increasing Demand for Personalized Medicine
  • 1.6.2 Market Challenges
    • 1.6.2.1 High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
    • 1.6.2.2 Shortage of Skilled Professionals
  • 1.6.3 Business Strategies
    • 1.6.3.1 Key Product Launch/Expansion
  • 1.6.4 Corporate Strategies
    • 1.6.4.1 Key Partnerships
    • 1.6.4.2 Key Funding and Grants
    • 1.6.4.3 Key Merger and Acquisitions
  • 1.6.5 Market Opportunities
    • 1.6.5.1 Expanding Proteomics Market in Emerging Regions through Affordable Technologies
• 1.7 Regulatory Landscape/Compliance
  • 1.7.1 Rest-of-the-World
    • 1.7.1.1 China
      • 1.7.1.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
    • 1.7.1.2 Japan
      • 1.7.1.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
• 1.8 Patent Analysis
  • 1.8.1 Patent Analysis (by Year)
  • 1.8.2 Patent Analysis (by Country)

2 Region

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 By Offering
    • 2.2.4.1 By Proteomics Technologies
  • 2.2.5 By Application
  • 2.2.6 By Country
    • 2.2.6.1 Japan
      • 2.2.6.1.1 By Offering
      • 2.2.6.1.2 By Application
    • 2.2.6.2 China
      • 2.2.6.2.1 By Offering
      • 2.2.6.2.2 Application
    • 2.2.6.3 India
      • 2.2.6.3.1 By Offering
      • 2.2.6.3.2 By Application
    • 2.2.6.4 Australia
      • 2.2.6.4.1 By Offering
      • 2.2.6.4.2 By Application
    • 2.2.6.5 South Korea
      • 2.2.6.5.1 By Offering
      • 2.2.6.5.2 By Application
    • 2.2.6.6 Rest-of-Asia-Pacific
      • 2.2.6.6.1 By Offering
      • 2.2.6.6.2 By Application

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Company Profile
  • 3.1.1 Shimadzu Corporation
    • 3.1.1.1 Overview
    • 3.1.1.2 Top Products/Product Portfolio
    • 3.1.1.3 Top Competitors
    • 3.1.1.4 Target Customers
    • 3.1.1.5 Key Personal
    • 3.1.1.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast